SWISS TXT: First Ever Cloud-Based Live Subtitles for the European Handball Championships in Croatia – a Solution for MTG TV Norway
By migrating subtitling infrastructure to its own cloud, SWISS TXT is revolutionising the live subtitling market with a reasonably-priced SaaS solution. The service was first used for MTG TV Norway at the European Handball Championships in Croatia.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180209005257/en/
Live subtitling in the cloud (Photo: Business Wire)
SWISS TXT has transferred the live subtitling infrastructure to its own cloud. This makes it possible to produce live subtitles more flexibly, quickly and cheaply than ever before. The server is now set up and operated automatically and regardless of location, allowing broadcasters to do away with costly subtitling infrastructure.
The live TV signal from the European Handball Championships in Croatia is sent to MTG TV Norway in Oslo, where SWISS TXT taps into the stream and moves it to the SWISS TXT Media Cloud for future use. BTI Studios, an established provider of access services in Europe, automatically receives a low-res version of the stream from the cloud and subtitles it live into Norwegian. The subtitled stream is then transmitted via Media Cloud from SWISS TXT to the MTG Broadcasting Centre in London, where the signal is broadcast to viewers in Norway.
Using this pay-as-you-go solution means that MTG TV Norway can broadcast subtitles at a lower cost as it is no longer forced to operate its own infrastructure.
Andreas Bakka Hjertø, Program Director at MTG TV Norway: “We are always excited to try new technology, and I’m happy to say that the solution for live subtitles for the European Handball Championships worked very well for us”.
Robert Holmström, CTO at BTI Studios: “As a leading provider of localization services, we are always seeking ways to improve workflows for our clients. SWISS TXT’s Media Cloud provides efficiencies in live subtitling, enabling BTI’s in-house subtitlers to connect with MTG’s systems for a smoother delivery of live subtitling services”.
Find out more about this service: Visit us at NAB Las Vegas, Stand SU6710.
ABOUT SWISS TXT
SWISS TXT is an established service provider for digital media, video streaming and access services. SWISS TXT acts as a centre of media expertise for its parent company SRG, and has been guiding Switzerland on its journey into an increasingly complicated digital future since 1983.
Find out more at www.swisstxt.ch
|■ Wholly-owned subsidiary of SRG SSR||■ Facilities in Biel, Zurich, Geneva, Comano|
|■ 168 employees (110 full-time staff)||■ Revenue in 2016: CHF 21.4 million|
ABOUT MTG TV NORWAY
MTG (Modern Times Group MTG AB (publ.)) is a leading international digital entertainment group and we are shaping the future of entertainment by connecting consumers with the content that they love in as many ways as possible. Our brands span TV, radio and next generation entertainment experiences in e-sports, digital video networks and online gaming. Born in Sweden, our shares are listed on Nasdaq Stockholm (‘MTGA’ and ‘MTGB’).
ABOUT BTI STUDIOS
BTI Studios is among the world’s largest and most renowned localization companies providing dubbing, subtitling, and access services in any language. Founded in 1995 as Broadcast Text, BTI Studios today operates 21 local facilities globally, spanning a network of fully owned local sites across Europe, Asia and the US. BTI Studios’ clients are broadcasters, such as BBC Worldwide, Discovery Networks and Turner; major film studios such as NBC Universal, Warner, Disney and Fox; and VoD Platforms, such as Amazon, Netflix and Hulu.
Head of Communications & PR
Tel +41 (0)32 329 2212
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Ultra-Low Power Lattice sensAI Leads Mass Market Enablement of Artificial Intelligence in Edge Devices21.5.2018 12:00 | Pressemelding
Lattice Semiconductor Corporation (NASDAQ: LSCC) today unveiled Lattice sensAI™ – a complete technology stack combining modular hardware kits, neural network IP cores, software tools, reference designs and custom design services – to accelerate integration of machine learning inferencing into broad market IoT applications. With solutions optimized for ultra-low power consumption (under 1 mW–1 W), small package size (5.5 mm2 –100 mm2), interface flexibility (MIPI® CSI-2, LVDS, GigE, etc.), and high-volume pricing (~$1-$10 USD), Lattice sensAI stack fast-tracks implementation of edge computing close to the source of data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005011/en/ (Graphic: Business Wire) “Lattice sensAI addresses the unmet need for flexible, low cost, ultra-low power AI silicon solutions suited for rapid deployment across a wide range of emerging, mass market IoT applications,” said Deepak Boppana, senior
NioCorp Awards Contract to Rockwell Automation on Groundbreaking Critical Minerals, Mining and Processing Facility in Nebraska21.5.2018 12:00 | Pressemelding
NioCorp Developments Ltd. (TSX: NB, OTCQX: NIOBF), a developer of superalloy metals, has awarded a major contract to Rockwell Automation (NYSE: ROK) to engineer, design and procure process automation and instrumentation for NioCorp’s proposed critical minerals, mining and processing facility in Elk Creek, Nebraska. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005228/en/ Three superalloy metals – niobium, scandium and titanium – are expected to be produced by the facility as early as 2021. These critical materials are used in the aerospace, defense, automotive, clean energy, commercial aviation and mega-infrastructure sectors. Generally, these superalloys enable increased strength and lighter weight in transportation and other systems, leading to better fuel efficiency and lower greenhouse gas and other air emissions, according to NioCorp. “We selected Rockwell Automation and its partners to automate our process equip
Biosimilars could facilitate early access to life changing biological treatments for patients says Celltrion Healthcare21.5.2018 11:27 | Pressemelding
At the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting in Baltimore, Celltrion Healthcare today advocated for healthcare systems to introduce biologics earlier in a patient’s treatment regimen in order to improve clinical outcomes. Several studies show that the early introduction of biologics can bring greater clinical benefit to patients.1,2,3,4,5,6 However, only a limited number of patients have access to biological treatment due to the high-cost of biologics and current reimbursement policies determined by pharmacoeconomic evaluations. Since the introduction of biosimilars, the overall cost of biological treatments has reduced in Europe, allowing an increased number of patients to access this important treatment option earlier in their course of treatment.7 Professor Jørgen Jahnsen said, “For the treatment of inflammatory bowel disease, biological treatments are proven to be the most efficacious medical therapy and their ea
Dole’s Joint Venture Recycling Company Celebrates 25 Years21.5.2018 11:00 | Pressemelding
Dole Food Company announced today that Recyplast S.A., an innovative plastic recycling company based in Costa Rica and with joint ownership including a subsidiary of Dole Fresh Fruit, recently surpassed 25 years in its mission to dramatically reduce and reuse agricultural waste. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005160/en/ Raul Martinez (right), General Manager of Dole Standard Fruit de Costa Rica, receives a plaque from Jose Miguel Ramirez, General Manager of Recyplast, in recognition of the contribution of Dole's banana plantations in the correct handling, storage, and provision of field plastic waste. The plastic recycling facility pioneered the collection of field plastics after use in banana growing operations in Costa Rica. This reuse and recycling process includes reclamation of plastic bags that protect bananas from weather and insects, as well as the collection of plastic twine used to prop the ba
ViiV Healthcare Receives EU Marketing Authorisation for Juluca (dolutegravir/rilpivirine), the First 2-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV21.5.2018 10:11 | Pressemelding
ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the European Commission has granted marketing authorisation for Juluca (dolutegravir 50mg/rilpivirine 25mg) for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor or integrase inhibitor.1 Juluca is a 2-drug regimen of dolutegravir (ViiV Healthcare), the most widely prescribed integrase inhibitor worldwide,2 and rilpivirine (Janssen Sciences Ireland UC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson).1 Deborah Waterhouse, CEO ViiV Healthcare said, “The European Commission Decision for Juluca is very positive news for people living with
Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-121.5.2018 10:06 | Pressemelding
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission has granted marketing authorisation for JULUCA® (dolutegravir 50mg [ViiV Healthcare]/rilpivirine 25mg [Janssen Sciences Ireland UC]).1 ViiV Healthcare, as the marketing authorisation holder, will market dolutegravir/rilpivirine in all countries in the European Union and European Economic Area. Dolutegravir/rilpivirine is the first two-drug regimen, once-daily, single-pill for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase inhibitor (INI).1 “The European Commission Decision for dolutegravir/rilpivirine marks a significant milestone in our 25-year commitment to make HIV history,” said Brian Woo